ÂÜÀòÂÒÂ×

Daniel Whiting is an accomplished IT professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the IT Director at Quell Therapeutics since November 2024, Daniel previously held positions including Head of IT and Innovation and Senior Manager, IT and Innovation, Europe at CNX Therapeutics from August 2021 to September 2024. Prior to that, Daniel worked at Sunovion Pharmaceuticals Europe Ltd. as Senior Manager, IT and Innovation, Europe, and held IT roles at Celtic Pharma Development Services Europe Ltd. and Xenova Group PLC. Daniel's academic credentials include an MSc in Cyber Security and a Professional Certificate in Management from The Open University, alongside a degree in Chemistry with Computer Science from the University of Reading.